Skip to main content

Advertisement

Table 2 Expression differences of selected mRNA in the validation cohort identified using qPCR

From: Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma

mRNA fold change (mean) cancer normal ROC analysis area under the curve
mean median mean median
SLC6A3 230 379.006 335.639 1.645 0.810 0.955 (0.906-1.000)
NPTX2 188 246.544 107.117 1.314 0.595 0.993 (0.982-1.000)
TNFAIP6 100 170.493 60.204 1.701 0.944 0.980 (0.947-1.000)
NDUFA4L2 78 104.866 78.748 1.337 0.861 0.996 (0.989-1.000)
ENPP3 42 58.365 44.022 1.382 1.049 0.977 (0.939-1.000)
FABP6 39 49.888 11.631 1.279 0.948 0.677 (0.555-0.800)
SPINK13 26 51.221 20.516 1.948 0.939 0.894 (0.831-0.957)
FXYD4 −2371 0.001 0.000 2.371 1.179 0.998 (0.994-1.000)
SLC12A1 −912 0.002 0.000 1.596 1.352 1.000 (1.000-1.000)
KNG1 −758 0.002 0.000 1.602 1.259 1.000 (0.998-1.000)
NPHS2 −407 0.005 0.000 1.986 1.944 0.970 (0.936-1.000)
SLC13A3 −62 0.030 0.004 2.039 1.836 0.970 (0.943-0.997)
GCGR −27 0.047 0.000 1.291 1.195 0.983 (0.951-1.000)
PLG −21 0.113 0.006 2.406 1.401 0.927 (0.880-0.975)